|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expenses | |||||
| Research and development | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Income from operations | |||||
| Interest income | |||||
| Other income | |||||
| Income before income taxes | |||||
| Provision for income taxes | |||||
| Net income | |||||
| Undeclared dividends on Series A preferred stock | |||||
| Net income (loss) attributable to common stock | |||||
| Foreign currency translation adjustments, net of tax | |||||
| Comprehensive income | |||||
| Net income per share | |||||
| Basic | |||||
| Diluted | |||||
| Weighted-average number of shares used to compute net income per share | |||||
| Basic | |||||
| Diluted |
Loading...
